The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Gareev I.F.

Bashkir State Medical University of the Ministry of Health of the Russian Federation

Beylerli O.A.

Bashkir State Medical University of the Ministry of Health of the Russian Federation

Abduganiev S.A.

The Clinic of Bashkir State Medical University

Guang Yang

First-Affiliated Hospital of Harbin Medical University

Shiguang Zhao

First-Affiliated Hospital of Harbin Medical University

Circulating micro-RNAs as biomarkers in brain tumors

Authors:

Gareev I.F., Beylerli O.A., Abduganiev S.A., Guang Yang, Shiguang Zhao

More about the authors

Journal: Russian Journal of Preventive Medicine. 2021;24(5): 51‑59

DOI: 10.17116/profmed20212405151

Read: 1483 times

Download PDF (RU)
Contact the author
Table of contents

CIRCULATING MICRO-RNAS AS BIOMARKERS IN BRAIN TUMORS
CIRCULATING MICRO-RNAS AS BIOMARKERS IN BRAIN TUMORS

To cite this article:

Gareev IF, Beylerli OA, Abduganiev SA, Guang Yang, Shiguang Zhao. Circulating micro-RNAs as biomarkers in brain tumors. Russian Journal of Preventive Medicine. 2021;24(5):51‑59. (In Russ.)
https://doi.org/10.17116/profmed20212405151

 
Подписка 2026 Профилактическая медицина (Russian Journal of Preventive Medicine)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Inflammatory aging. Part 1. The principal biochemical mechanisms. Russian Journal of Preventive Medi­cine. 2024;(12):145-150
Inflammatory aging. Part 2. Are there diagnostic biomarkers available. Russian Journal of Preventive Medi­cine. 2025;(1):89-95
Diagnosis of neuroinfections in children. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11-2):51-59
Labo­ratory biomarkers for the prognosis of chro­nic heart failure. Labo­ratory Service. 2024;(3):5-16
The role of immuno-inflammatory factors in the deve­lopment of nega­tive symptoms in schi­zophrenia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):42-48
Deve­lopment of a method for moxo­nidine quantification in blood and urine by high-performance liquid chro­matography with tandem mass-selective dete­ction. Fore­nsic Medi­cal Expe­rtise. 2024;(6):42-47
Characteristics of postmortem changes in the brain. Fore­nsic Medi­cal Expe­rtise. 2024;(6):56-61
Prognosis and prevention of recu­rrent and atypical endo­metrial hype­rplasia in women of reproductive age. Russian Bulletin of Obstetrician-Gynecologist. 2024;(6):59-65
The influence of neurofeedback on the β-rhythm of the brain on the characteristics of atte­ntion in athletes with different training orientations. Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(6-2):20-25
The expe­rience of diagnosing Alzheimer’s disease based on the study of cere­brospinal fluid biomarkers. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):91-97
Abstract:

Brain tumors, especially malignant forms such as glioblastoma multi-form are usually difficult to diagnose and existing treatments are usually not satisfactory. Patients’ monitoring with brain neoplasms is challenging due to the complexity and risk of biopsy, as well as the low specificity and sensitivity of currently available minimally invasive diagnostic methods. Uncertainty about diagnosis and the tumor’s respond to treatment can delay further decisions that affect outcome. Therefore, there is an urgent need for the development and validation of reliable and minimally invasive biomarkers for the diagnosis and prognosis of brain tumors that could be used alone or in combination in current clinical practice. It is known that circulating microRNAs are in a stable form and are detected in human biological fluids, such as blood, urine, cerebrospinal fluid (CSF), and saliva. In this regard, circulating microRNAs are considered as new biomarkers in a number of diseases including brain tumors. The results of many studies have shown that it is possible to profile the expression of circulating miRNAs both in the CSF and in the blood of patients with brain tumors. Some specific circulating miRNAs are expressed differently in CSF while others are expressed in blood. Circulating microRNAs found in the blood can be informative in diagnosing, predicting and tracking the effectiveness of treatment for different types of tumors. However, circulating microRNAs in the blood turned out to be suboptimal for diagnosing brain tumors while the profile of circulating microRNAs in CSF promises a more accurate and specific assessment for brain tumors.

Keywords:

circulating microRNAs
blood
cerebrospinal fluid
expression
biomarkers
tumor
brain

Authors:

Gareev I.F.

Bashkir State Medical University of the Ministry of Health of the Russian Federation

Beylerli O.A.

Bashkir State Medical University of the Ministry of Health of the Russian Federation

Abduganiev S.A.

The Clinic of Bashkir State Medical University

Guang Yang

First-Affiliated Hospital of Harbin Medical University

Shiguang Zhao

First-Affiliated Hospital of Harbin Medical University

Received:

07.07.2020

Accepted:

11.01.2021

Close metadata

References:

  1. Aldape K, Brindle KM, Chesler L, Chopra R, Gajjar A, Gilbert MR, Gottardo N, Gutmann DH, Hargrave D, Holland EC, Jones DTW, Joyce JA, Kearns P, Kieran MW, Mellinghoff IK, Merchant M, Pfister SM, Pollard SM, Ramaswamy V, Rich JN, Robinson GW, Rowitch DH, Sampson JH, Taylor MD, Workman P, Gilbertson RJ. Challenges to curing primary brain tumours. Nat Rev Clin Oncol. 2019;16(8):509-520.  https://doi.org/10.1038/s41571-019-0177-5
  2. Lowery FJ, Yu D. Brain metastasis: Unique challenges and open opportunities. Biochim Biophys Acta Rev Cancer. 2017;1867(1):49-57.  https://doi.org/10.1016/j.bbcan.2016.12.001
  3. Nandu H, Wen PY, Huang RY. Imaging in neuro-oncology. Ther Adv Neurol Disord. 2018;11:1756286418759865. https://doi.org/10.1177/1756286418759865
  4. Nevel KS, Wilcox JA, Robell LJ, Umemura Y. The Utility of Liquid Biopsy in Central Nervous System Malignancies. Curr Oncol Rep. 2018;20(8):60.  https://doi.org/10.1007/s11912-018-0706-x
  5. Shen F, Zhang Y, Yao Y, Hua W, Zhang HS, Wu JS, Zhong P, Zhou LF. Proteomic analysis of cerebrospinal fluid: toward the identification of biomarkers for gliomas. Neurosurg Rev. 2014;37(3):367-380.  https://doi.org/10.1007/s10143-014-0539-5
  6. Khan Z, Suthanthiran M, Muthukumar T. MicroRNAs and Transplantation. Clin Lab Med. 2019;39(1):125-143.  https://doi.org/10.1016/j.cll.2018.10.003
  7. Terrinoni A, Calabrese C, Basso D, Aita A, Caporali S, Plebani M, Bernardini S. The circulating miRNAs as diagnostic and prognostic markers. Clin Chem Lab Med. 2019;57(7):932-953.  https://doi.org/10.1515/cclm-2018-0838
  8. Rizzo FM, Meyer T. Liquid Biopsies for Neuroendocrine Tumors: Circulating Tumor Cells, DNA, and MicroRNAs. Endocrinol Metab Clin North Am. 2018;47(3):471-483.  https://doi.org/10.1016/j.ecl.2018.04.002
  9. Lianidou E, Pantel K. Liquid biopsies. Genes Chromosomes Cancer. 2019; 58(4):219-232.  https://doi.org/10.1002/gcc.22695
  10. Sibíkova M, Zivny J, Janota J. Cell Membrane-Derived Microvesicles in Systemic Inflammatory Response. Folia Biol (Praha). 2018;64(4):113-124. 
  11. Wortzel I, Dror S, Kenific CM, Lyden D. Exosome-Mediated Metastasis: Communication from a Distance. Dev Cell. 2019;49(3):347-360.  https://doi.org/10.1016/j.devcel.2019.04.011
  12. Wilhelm EN, Mourot L, Rakobowchuk M. Exercise-Derived Microvesicles: A Review of the Literature. Sports Med. 2018;48(9):2025-2039. https://doi.org/10.1007/s40279-018-0943-z
  13. Wang Z, Chen JQ, Liu JL, Tian L. Exosomes in tumor microenvironment: novel transporters and biomarkers. J Transl Med. 2016;14(1):297.  https://doi.org/10.1186/s12967-016-1056-9
  14. Sheu-Gruttadauria J, Xiao Y, Gebert LF, MacRae IJ. Beyond the seed: structural basis for supplementary microRNA targeting by human Argonaute2. EMBO J. 2019;pii:e101153. https://doi.org/10.15252/embj.2018101153
  15. Hirose T. Brain tumor pathology. Preface to special issue. Brain Tumor Pathol. 2015;32(1):1-2.  https://doi.org/10.1007/s10014-014-0209-x
  16. Dietrich J, Winter SF, Klein JP. Neuroimaging of Brain Tumors: Pseudoprogression, Pseudoresponse, and Delayed Effects of Chemotherapy and Radiation. Semin Neurol. 2017;37(5):589-596.  https://doi.org/10.1055/s-0037-1608657
  17. Reardon DA, Weller M. Pseudoprogression: fact or wishful thinking in neuro-oncology? Lancet Oncol. 2018;19(12):1561-1563. https://doi.org/10.1016/S1470-2045(18)30654-5
  18. Villanueva-Meyer JE, Mabray MC, Cha S. Current Clinical Brain Tumor Imaging. Neurosurgery. 2017;81(3):397-415.  https://doi.org/10.1093/neuros/nyx103
  19. Wang H., Peng R., Wang J. Qin Z, Xue L. Circulating microRNAs as potential cancer biomarkers: the advantage and disadvantage. Clin Epigenetics. 2018;10:59.  https://doi.org/10.1186/s13148-018-0492-1
  20. Hamam R, Hamam D, Alsaleh KA. Circulating microRNAs in breast cancer: novel diagnostic and prognostic biomarkers. Cell Death Dis. 2017;8(9): e3045. https://doi.org/10.1038/cddis.2017.440
  21. Chmielewska N, Szyndler J, Makowska K. Wojtyna D, Maciejak P, Płaźnik A. Looking for novel, brain-derived, peripheral biomarkers of neurological disorders. Neurol Neurochir Pol. 2018;52(3):318-325.  https://doi.org/10.1016/j.pjnns.2018.02.002
  22. Yan J, Li X, Peng L, Shen X, Dang Y, Zhang G. MicroRNA-150 as a Potential Biomarker in Diagnosis of Cancer: a Meta-Analysis. Clin Lab. 2017;63(7): 1187-1197. https://doi.org/10.7754/Clin.Lab.2017.170522
  23. Ma C, Nguyen HPT, Luwor RB, Stylli SS, Gogos A, Paradiso L, Kaye AH, Morokoff AP. A comprehensive meta-analysis of circulation miRNAs in glioma as potential diagnostic biomarker. PLoS One. 2018;13(2):e0189452. https://doi.org/10.1371/journal.pone.0189452
  24. Sorensen SS, Nygaard AB, Nielsen MY, Jensen K, Christensen T. MiRNA Expression Profiles in Cerebrospinal Fluid and Blood of Patients with Acute Ischemic Stroke. Transl Stroke Res. 2014;5(6):711-718.  https://doi.org/10.1007/s12975-014-0364-8
  25. Gargiulo E, Paggetti J, Moussay E. Hematological Malignancy-Derived Small Extracellular Vesicles and Tumor Microenvironment: The Art of Turning Foes into Friends. Cells. 2019;8(5):E511. https://doi.org/10.3390/cells8050511
  26. Manek R, Moghieb A, Yang Z, Kumar D, Kobeissy F, Sarkis GA, Raghavan V, Wang KKW. Protein Biomarkers and Neuroproteomics Characterization of Microvesicles/Exosomes from Human Cerebrospinal Fluid Following Traumatic Brain Injury. Mol Neurobiol. 2018;55(7):6112-6128. https://doi.org/10.1007/s12035-017-0821-y
  27. Teunissen CE, Verheul C, Willemse EAJ. The use of cerebrospinal fluid in biomarker studies. Handb Clin Neurol. 2017;146:3-20.  https://doi.org/10.1016/B978-0-12-804279-3.00001-0
  28. Fernando MR, Jiang C, Krzyzanowski GD. New evidence that a large proportion of human blood plasma cell-free DNA is localized in exosomes. PLoS One. 2017;12(8):e0183915. https://doi.org/10.1371/journal.pone.0183915
  29. Kusuma GD, Barabadi M, Tan JL. To Protect and to Preserve: Novel Preservation Strategies for Extracellular Vesicles. Front Pharmacol. 2018;9:1199. https://doi.org/10.3389/fphar.2018.01199
  30. Nilsson RJ, Balaj L, Hulleman E, van Rijn S, Pegtel DM, Walraven M, Widmark A, Gerritsen WR, Verheul HM, Vandertop WP, Noske DP, Skog J, Würdinger T. Blood platelets contain tumor-derived RNA biomarkers. Blood. 2011;118(13): 3680-3683.
  31. Best MG, Sol N, Zijl S, Reijneveld JC, Wesseling P, Wurdinger T. Liquid biopsies in patients with diffuse glioma. Acta Neuropathol. 2015;129(6):849-865.  https://doi.org/10.1007/s00401-015-1399-y
  32. Shao H, Chung J, Lee K, Balaj L, Min C, Carter BS. Chip-based analysis of exosomal mRNA mediating drug resistance in glioblastoma. Nat Commun. 2015;6:6999. https://doi.org/10.1038/ncomms7999
  33. Yagi Y, Ohkubo T, Kawaji H, Machida A, Miyata H, Goda S, Roy S, Hayashizaki Y, Suzuki H, Yokota T. Next-generation sequencing-based small RNA profiling of cerebrospinal fluid exosomes. Neurosci Lett. 2017;636:48-57.  https://doi.org/10.1016/j.neulet.2016.10.042
  34. Yang H, Wang Y. Five miRNAs considered as molecular targets for predictingneuroglioma. Tumour Biol. 2016;37(1):1051-1059. https://doi.org/10.1007/s13277-015-3898-9
  35. Miida T, Yamada T, Seino U, Ito M, Fueki Y, Takahashi A, Kosuge K, Soda S, Hanyu O, Obayashi K, Miyazaki O, Okada M. Serum amyloid a (SAA)-induced remodeling of CSF-HDL. Biochim Biophys Acta. 2006;1761(4):424-433.  https://doi.org/10.1016/j.bbalip.2006.03.013
  36. Hirsch-Reinshagen V, Donkin J, Stukas S, Chan J, Wilkinson A, Fan J, Parks JS, Kuivenhoven JA, Lütjohann D, Pritchard H, Wellington CL. LCAT synthesized by primary astrocytes esterifies cholesterol on glia-derived lipoproteins. J Lipid Res. 2009;50:885-893.  https://doi.org/10.1194/jlr.M800584-JLR200
  37. Lv YC, Tang YY, Peng J, Zhao GJ, Yang J, Yao F, Ouyang XP, He PP, Xie W, Tan YL, Zhang M, Liu D, Tang DP, Cayabyab FS, Zheng XL, Zhang DW, Tian GP, Tang CK. MicroRNA-19b promotes macrophage cholesterol accumulation and aortic atherosclerosis by targeting ATP-binding cassette transporter A1. Atherosclerosis. 2014;236(1):215-226.  https://doi.org/10.1016/j.atherosclerosis.2014.07.005
  38. Dunn BK, Wagner PD, Anderson D, Greenwald P. Molecular Markers for Early Detection. Semin Oncol. 2010;37(3):224-242.  https://doi.org/10.1053/j.seminoncol.2010.05.007
  39. Rao AM, Quddusi A, Shamim MS. The significance of MGMT methylation in Glioblastoma Multiforme prognosis. J Pak Med Assoc. 2018;68(7): 1137-1139.
  40. Wang J, Che F, Zhang J, Zhang M, Xiao S, Liu Y, Zhou L, Su Q, You C, Lu Y, Heng X. Diagnostic and Prognostic Potential of Serum Cell-Free microRNA-214 in Glioma. World Neurosurg. 2019;125:1217-1225. https://doi.org/10.1016/j.wneu.2019.02.009
  41. Zhi F, Shao N, Li B, Xue L, Deng D, Xu Y, Lan Q, Peng Y, Yang Y. A serum 6-miRNA panel as a novel non-invasive biomarker for meningioma. Sci Rep. 2016;6:32067. https://doi.org/10.1038/srep32067
  42. Zhang H, Wang J, Wang Z, Ruan C, Wang L, Guo H. Serum miR-100 is a potential biomarker for detection and outcome prediction of glioblastoma patients. Cancer Biomark. 2019;24(1):43-49.  https://doi.org/10.3233/CBM-181416
  43. Shi R, Wang PY, Li XY, Chen JX, Li Y, Zhang XZ, Zhang CG, Jiang T, Li WB, Ding W, Cheng SJ. Exosomal levels of miRNA-21 from cerebrospinal fluids associated with poor prognosis and tumor recurrence of glioma patients. Oncotarget. 2015;6(29):26971-26981. https://doi.org/10.18632/oncotarget.4699
  44. Zhi F, Shao N, Li B, Xue L, Deng D, Xu Y, Lan Q, Peng Y, Yang Y. Identification of Serum miRNA-423-5p Expression Signature in Somatotroph Adenomas. Sci Rep. 2016;6:32067. https://doi.org/10.1038/srep32067
  45. Németh K, Darvasi O, Likó I, Szücs N, Czirják S, Reiniger L, Szabó B, Krokker L, Pállinger É, Igaz P, Patócs A, Butz H. Comprehensive analysis of circulating microRNAs in plasma of patients with pituitary adenomas. J Clin Endocrinol Metab. 2019;pii:jc.2018-02479. https://doi.org/10.1210/jc.2018-02479
  46. Drusco A, Bottoni A, Laganà A, Acunzo M, Fassan M, Cascione L, Antenucci A, Kumchala P, Vicentini C, Gardiman MP, Alder H, Carosi MA, Ammirati M, Gherardi S, Luscrì M, Carapella C, Zanesi N, Croce CM. A differentially expressed set of microRNAs in cerebro-spinal fluid (CSF) can diagnose CNS malignancies. Oncotarget. 2015;6(25):20829-39.  https://doi.org/10.18632/oncotarget.4096
  47. Roberts TS, Coenen-Stass AML, Corinne AB, Wood MJA. Detection and quantification of extracellular microRNAs in medulloblastoma. Biol Proced Online. 2014;16:5.  https://doi.org/10.1186/1480-9222-16-5
  48. Sato J, Shimomura A, Kawauchi J, Matsuzaki J, Yamamoto Y, Takizawa S, et al. Brain metastasis-related microRNAs in patients with advanced breast cancer. PLoS One. 2019;14(10):e0221538. https://doi.org/10.1371/journal.pone.0221538
  49. Jiang LP, Zhu ZT, Zhang Y, He CY. Downregulation of MicroRNA-330 Correlates with the Radiation Sensitivity and Prognosis of Patients with Brain Metastasis from Lung Cancer. Cell Physiol Biochem. 2017;42(6):2220-2229. https://doi.org/10.1159/000479996
  50. Bookland M, Gillan E, Song X, Kolmakova A. Peripheral circulation miRNA expression of pediatric brain tumors and its relation to tumor miRNA expression levels. J Neurosurg Pediatr (Online ahead of print). 2020;1-9.  https://doi.org/10.3171/2020.2.PEDS19715
  51. Lee KH, Chen YL, Yeh SD, Hsiao M, Lin JT, Goan YG, Lu PJ. MicroRNA-330 acts as tumor suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation. Oncogene. 2009;28(38):3360-3370. https://doi.org/10.1038/onc.2009.192
  52. Pang Y, Young CY, Yuan H. MicroRNAs and prostate cancer. Acta Biochim Biophys Sin (Shanghai). 2010;42:363-369.  https://doi.org/10.1093/abbs/gmq038
  53. Li Y, Zhu X, Xu W, Wang D, Yan J. miR-330 regulates the proliferation of colorectal cancer cells by targeting Cdc42. Biochem Biophys Res Commun 2013;431:560-565.  https://doi.org/10.1016/j.bbrc.2013.01.016
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.